Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Accolade Inc
(NQ:
ACCD
)
4.130
-0.020 (-0.48%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Accolade Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Expert Ratings for Accolade
November 22, 2023
Via
Benzinga
Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday
November 14, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 500 points on Tuesday. Shares of Azenta, Inc. (NASDAQ: AZTA) rose on Tuesday after the company reported better-than-expected fourth-quarter...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
1 Market-Beating Stock to Buy Near Its 52-Week High
October 19, 2023
This stock has been firing on all cylinders -- and it isn't about to stop.
Via
The Motley Fool
Alignment Healthcare's Valuation Shows Promise In A Competitive Market: Analyst
October 16, 2023
Alignment Healthcare Inc (NASDAQ: ALHC) announced that its California Medicare Advantage (MA) HMO – which represents roughly 89% of its MA membership – has maintained an overall 4 out of 5-star rating...
Via
Benzinga
Why Shares of Accolade Fell This Week
October 06, 2023
The company's fiscal 2024 second-quarter numbers showed improvement, but analysts and investors were not impressed.
Via
The Motley Fool
Earnings Outlook For Accolade
October 03, 2023
Via
Benzinga
The Latest Analyst Ratings for Accolade
August 14, 2023
Via
Benzinga
Obesity Medication Insurance Coverage? Employers Embrace the Inclusion of Novo Nordisk's Wegovy in Health Coverage
October 10, 2023
Coverage for obesity medications, including Novo Nordisk A/S's (NYSE: NVO) Wegovy, is expected to expand among U.S.
Via
Benzinga
Why Eli Lilly Stock Crawled Higher Today
October 09, 2023
The pharmaceutical giant gets a lift from some good news on insurance coverage and a prognosticator's price-target lift.
Via
The Motley Fool
Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
October 05, 2023
Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by Japan's Kyowa Kirin for $16.00 per ADS in cash plus an additional contingent...
Via
Benzinga
Raymond James Maintains Outperform Rating for Accolade: Here's What You Need To Know
October 05, 2023
Via
Benzinga
Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket
October 05, 2023
Gainers
Via
Benzinga
MaxCyte, Rivian Automotive And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
October 05, 2023
U.S. stock futures traded lower this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Conagra Brands, Constellation Brands And 3 Stocks To Watch Heading Into Thursday
October 05, 2023
With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 04, 2023
Via
Benzinga
Why Accolade Stock Is Falling After-Hours
October 04, 2023
Accolade, Inc. (NASDAQ: ACCD) shares are trading lower after-hours on Wednesday after the company announced results for the second-quarter 2024
Via
Benzinga
Accolade Announces Results for Fiscal Second Quarter 2024
October 04, 2023
From
Accolade, Inc.
Via
GlobeNewswire
Accolade Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
October 04, 2023
Accolade, Inc. (NASDAQ: ACCD) is expected to release financial results for its fiscal second quarter 2024 after the closing bell on Oct. 4, 2023.
Via
Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
September 01, 2023
The widely followed growth investor went stock shopping on the final trading day in August.
Via
The Motley Fool
Cathie Wood Just Sold Nvidia -- and Bought These 5 Potentially Explosive Growth Stocks Again
August 30, 2023
The famous growth investor has been making some interesting stock moves lately.
Via
The Motley Fool
Cathie Wood's Bullish Stance on Flying Cars: Ark Buys $3.9M Worth of Archer Aviation Shares
August 28, 2023
Via
Benzinga
Cathie Wood's Ark Invest Adjusts Portfolio — Sells Nvidia Shares Worth Nearly $1.9M Amid AI Surge
August 24, 2023
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Cathie Wood Just Sold Shopify -- and Bought These 7 Potentially Explosive Growth Stocks
August 24, 2023
The Ark Invest CEO continues to trim Shopify holdings to fund some big purchases.
Via
The Motley Fool
Every AI Stock Cathie Wood Owns, Ranked From Best to Worst
August 12, 2023
You can find some great AI investment opportunities by looking at the stocks in Wood's Ark Invest portfolio.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports
August 07, 2023
Via
Benzinga
Cathie Wood's Ark Invest Acquires $5.5M of Robinhood Shares Following Platform's First Profitable Quarter
August 03, 2023
Via
Benzinga
Cathie Wood Continues Iridium Shopping Spree — Ark Invest Buys $3.6M Worth Of Satellite Company's Stock
August 02, 2023
Via
Benzinga
Downgrade Aside, Cathie Wood Buys $1.2M Worth Of SoFi Shares
July 27, 2023
Via
Benzinga
Cathie Wood's Ark Invest Buys Spotify, Iridium Shares — Trims Tesla, Coinbase Holdings
July 25, 2023
Via
Benzinga
Cathie Wood's Ark Invest Makes Major Moves In This Warren Buffett-Backed EV Company, Moderna
July 24, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.